Search IBA Dosimetry

SBRT part 2: The role of SBRT in the treatment of oligometastatic prostate cancer: Why & how SBRT for these patients

PD Dr. med. Stefan KörberFirst Senior Medical Doctor at Clinic for Radiation Oncology and Radiation Therapy
University Clinic of Heidelberg, Germany
3 min. (open access preview)16 min. (full presentation, members)

Learn how the oligometastatic status of prostate cancer patients is defined on the basis of PSMA PET/CT and which strategies and modalities are applied for SBRT treatment of these patients.

Related Presentations

SBRT part 1: Impact of PSMA PET on the management of patients with oligo metastatic prostate cancer
Discover
SBRT part 3: Quality assurance for SBRT treatments
Discover